Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience

Yafit Segman, Elena Ribakovsky, Abraham Avigdor, Yair Goldhecht, Vladimir Vainstein, Neta Goldschmidt, Shimrit Harlev, Netanel Horwitz, Odit Gutwein, Ronit Gurion, Gilad Itchaki, Uri Abadi, Anatoly Nemets, Orit Sofer, Miri Zektser, Tamar Tadmor, Nagib Dally, Kalman Filanovsky, Merav Leiba, Nadav SaridNoam Benyamini, Yair Herishanu, Ron Ram, Chava Perry, Irit Avivi

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience'. Together they form a unique fingerprint.

Medicine & Life Sciences